An audit of the assessment and management of adults admitted to Christchurch Hospital with community acquired pneumonia

New Zealand Medical Journal

Volumn 110, Issue 1052, 1997, Pages 349-352

  Meyer, R J ^a   Town, G I ^a   Harre E ^a   Koning, M ^a   Hurrell, M ^b   Beard, M E J ^b   Chambers, S T ^b  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b Donovan Scientific Insect Research   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; CEFUROXIME; ERYTHROMYCIN; GENTAMICIN; PENICILLIN G;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; FEMALE; HOSPITAL ADMISSION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MEDICAL AUDIT; NEW ZEALAND; ORAL DRUG ADMINISTRATION; PATIENT CARE; PHYSICAL EXAMINATION; PNEUMONIA; PRACTICE GUIDELINE; RISK ASSESSMENT; TREATMENT PLANNING;

ADULT; AGED; ANTI-BACTERIAL AGENTS; COMMUNITY-ACQUIRED INFECTIONS; DRUG THERAPY, COMBINATION; FEMALE; GUIDELINE ADHERENCE; HOSPITALS; HUMANS; MALE; MEDICAL AUDIT; NEW ZEALAND; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PATIENT ADMISSION; PNEUMONIA, BACTERIAL; PNEUMONIA, PNEUMOCOCCAL; PRACTICE GUIDELINES; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 0030810746     PISSN: 00288446     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Neill AM, Martin IR, Weir R, et al. Community acquired pneumonia: aetiology and usefulness of severity criteria on admission. Thorax 1996; 51: 1010-6.
2. British Thoracic Society: Guidelines for the management of community-acquired pneumonia in adults admitted to hospital. Br J Hosp Med 1993; 49: 346-50.
3. American Thoracic Society: Guidelines for the initial management of adults with community-acquired pneumonia: Diagnosis, assessment of severity, and initial antimicrobial therapy. Am Rev Respir Dis 1993; 148: 1418-26.
4. Bartlett JG, Mundy LM. Community acquired pneumonia. N Engl J Med 1995; 333: 1618-24.
5. Beard MEJ, editor. Management Guidelines for Common Medical Conditions 5th ed. Christchurch: Internal Medicine Services, Canterbury Health Limited; 1994.
6. Mugford M, Banfield P, O'Hanlon M. Effects of feedback of information on clinical practice: a review. BMJ 1991; 303: 398-402.
7. Grimshaw JM, Russell IT. Effect of clinical guidelines on medical practice: a systematic review of rigorous evaluations. Lancet 1993; 342: 1317-22.
8. Haines A, Feder G. Guidance on guidelines. BMJ 1992; 305: 785-6.
9. Woodhead MA, Arrowsmith J, Chamberlain-Webber R, et al. The value of routine microbial investigation in community acquired pneumonia. Respir Med 1990; 85: 313-7.
10. Harvey KJ, Stewart R, Hemming M, et al. Educational antibiotic advertising. Med J Aust 1986; 145: 28-32.
11. Research Committee of the British Thoracic Society. Community-acquired pneumonia in adults in British hospitals in 1982-1983: Survey of aetiology, mortality, prognostic factors and outcome. Q J Med 1987; 62:195-220.
12. Karalus NC, Cursons RT, Leng RA, et al. Community acquired pneumonia: aetiology and prognostic index evaluation. Thorax 1991; 46: 413-8.
13. Fang GD, Fine M, Orloff J, et al. New and emerging etiologies for community-acquired pneumonia with implications for therapy. Medicine 1990; 69: 307-16.
14. Lange P, Vesbo J, Nyboe J. Risk factors for death and hospitalisation from pneumonia. A prospective study of a general population. Eur Respir J 1995; 8: 1694-8.
15. Torres A, Ausina V. Empirical treatment of nonsevere community acquired pnaumonia: still a difficult issue. Eur Respir J 1995; 8: 1996-8.
16. Fein AM, Niederman MS. Guidelines for the initial management of community-acquired pneumonia: Savory recipe or cookbook for disaster? Am J Respir Crit Care Med 1995; 152: 1149-53.
17. Farr BM, Sloman AJ, Fisch MJ. Predicting death in patients hospitalised for community-acquired pneumonia. Ann Int Med 1991; 115: 428-36.
18. Fine MJ, Smith MA, Carson CA, et al. Prognosis and outcomes of patients with community-acquired pneumonia A meta-analysis. JAMA 1996; 275: 134-41.
19. Weingarten SR, Riedinger MS, Varis G, et al. Identification of low-risk hospitalised patients with pneumonia. Implications for early conversion to oral antimicrobial therapy. Chest 1994; 105: 1109-15.
20. Brancati FL, Chow JW, Wagener MM, et al. Is pneumonia really the old man's friend? Two-year prognosis after community-acquired pneumonia. Lancet 1993; 342: 30-3.
21. Chan R, Hemeryck L, O'Regan M, et al. Oral versus intravenous antibiotics for community acquired lower respiratory tract infection in a general hospital: open, randomized controlled trial. BMJ 1995; 310: 1360-2.
22. Ramirez JA, Srinath L, Ahkee S, et al. Early switch from intravenous to oral cephalosporins in the treatment of hospitalised patients with community acquired pneumonia. Arch Intern Med 1995; 155: 1273-6.
23. Lode H, Garau J, Grassi C, et al. Treatment of community-acquired pneumonia: a randomized comparison of sparfloxacin, amoxicillin-clavulanic acid and erythromycin. Eur Respir J 1995; 8: 1999-2007.
24. Nichol KL, Margolis KL, Wuorenma J, Von Sternberg T. The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community. N Engl J Med 1994; 331: 778-84.